phorylation (OXPHOS). 2,3 ATP can also be generated by the degradation of lipids, including triglycerides and phospholipids into fatty acids, which are metabolized in the mitochondria 
S
tem cell plasticity and differentiation strongly depend on specific metabolic pathways. Of particular relevance is the mechanism by which the cells generate ATP. ATP serves as an energy transport molecule that is responsible for fulfilling various cellular metabolic and energy demands in functional cells and organisms. ATP can be generated by glycolysis (for more details, see http://www.biocarta.com/pathfiles/h_ glycolysispathway.asp) through the breakdown of glucose 1 derived either from carbohydrates (http://www.biocarta.com/ pathfiles/feederPathway.asp) or through gluconeogenesis pathways from amino acids, glycerol, and lactate metabolism 1 (http://www.biocarta.com/pathfiles/glucogenicPathway.asp; Figure 1 ). The end product of the glycolytic pathway in the cytosol is pyruvate, which either can be further metabolized by lactate dehydrogenase to produce lactate (anaerobic glycolysis) or pyruvate, which can enter the mitochondria and be further converted into acetyl-coenzyme A (Acetyl-CoA) via the pyruvate dehydrogenase complex-mediated decarboxylation. Acetyl-CoA can then be metabolized by the Krebs cycle to generate NADH (and less flavin adenine dinucleotide 2 2 ; for more details, see http://www.biocarta.com/pathfiles/krebPathway.asp). Electrons from NADH or from succinate can be transferred independently via NADH:ubiquinone oxidoreductase (complex I) or via the succinate:ubiquinone oxidoreductase (complex II), respectively, to the lipid-soluble carrier, ubiquinone (Q). Electrons are then sequentially transferred to the ubiquinol:cytochrome c oxidoreductase (complex III), further to the cytochrome c oxidase (also known as complex IV) and finally to oxygen in the mitochondrial matrix. The entire electron transfer process contributes to generation of a H + gradient across the inner mitochondrial membrane, which is required for activation of ATP synthase (sometimes described as complex V) and ATP synthesis (http://www.biocarta.com/ pathfiles/h_etcPathway.asp).
2,3 ATP synthesis involving the respiratory chain is defined as the process of oxidative phosvia β-oxidation into Acetyl-CoA (http://www.biocarta.com/ pathfiles/betaoxidationPathway.asp). Acetyl-CoA flows into the Krebs cycle and finally leads to ATP synthesis through OXPHOS. 4 The biochemical degradation of 1 mol glucose by OXPHOS can generate a maximum of 38 mol ATP, whereas only 2 mol ATP can be generated by the anaerobic glycolysis pathway occurring in the cytosol.
Evidently, cellular metabolism influences several biological processes, such as proliferation, differentiation, and development. A clear link between a defined metabolic pathway and an increased proliferation rate has been recognized recently by advances in research on cancer cell metabolism. This link is well known as the Warburg effect. The Warburg effect characterizes the majority of highly proliferative and malignant cancer cells, describing a phenomenon in which tumor cell requirement for ATP is met by a high rate of anaerobic glycolysis followed by lactic acid fermentation to produce ATP rather than by glycolysis followed by aerobic oxidation of pyruvate in the mitochondria, which is characteristic of most normal cells. 5 Unlimited cell proliferation is a common feature of both cancer and pluripotent stem cells (PSCs), at least under in vitro culture conditions. Common signaling pathways playing an important role in self-renewal and in cancer cells include the Janus kinase/signal transducer and activator of transcription pathway, the Notch and Hedgehog signaling pathway, the mitogen-activated protein kinase and phosphoinositide-3-kinase/AKT pathways, the nuclear factor κ-light-chain enhancer of activated B cells and Wnt pathways, and the transforming growth factor β pathway. 6, 7 Apparently, common proliferation signaling pathways are regulated by cellular metabolism and energy sources. 6, 7 More than 25 years ago, it was also recognized that nutrition and metabolism influence the differentiation of lower, unicellular organisms, such as yeast and Streptomyces. [8] [9] [10] Moreover, a relationship between metabolism and cell differentiation has been recognized in the differentiation processes that occur during insect metamorphosis, which is accompanied by a prominent reduction in metabolic pathways such as glycolysis and fatty acid oxidation. 11 However, the role of metabolism in the development of animals from the embryo stage through the formation of tissue layers (eg, ectoderm, mesoderm, and endoderm) has heretofore remained unclear. Although it is clear that metabolic pathways influence cellular processes such as proliferation, differentiation, and quiescence, less is known about the mechanisms involved. Investigating the potential molecular metabolic pathways that characterize the in vivo developmental program during embryogenesis is challenging and time consuming. The developmental program can be partly recapitulated in vitro through the use of cultured PSCs, including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) that are capable of self-renewal and differentiation into specialized cells of the ectodermal, endodermal, and mesodermal germ layers and, in later stages, into somatic cell types. [12] [13] [14] [15] Adult stem cells, such as mesenchymal stem cells (MSCs) and neural stem cells, are quiescent cells capable of self-renewal for long periods of time and are only capable of differentiating into a few specialized cell types. In the past decade, significant progress has been made in the identification of genetic, epigenetic, and signal transduction pathways that control the stemness (ie, self-renewal) and differentiation fate of iPSCs. [16] [17] [18] [19] [20] [21] [22] [23] More recently, growing attention has been directed toward the significance of metabolism/metabolites in the pluripotency and differentiation of stem cells. In this context, it is hoped that (1) the identification of specific metabolic pathway signatures in the pluripotent state and during differentiation into specific somatic cells will provide us with molecular tools for manipulating the differentiation fate of stem cells and for manipulating the resultant somatic cells; (2) the identification of specific metabolic pathways will produce novel insights into the regulation of differentiation and have a great impact on the field of regenerative medicine; and (3) these metabolic signatures may contribute to our understanding of drug and environmental toxicity.
In this review, we summarize and discuss the existing literature about the role of metabolism in the pluripotency and differentiation of stem cells. Moreover, we have made an attempt to identify fundamental metabolic pathways involved in the differentiation of ESCs during pluripotency, as well as during early and late differentiation stages, using transcriptome analysis. We also analyzed the available transcriptome data of cardiovascular cell types derived from ESCs to identify prominent metabolic genes that are characteristic for each cell type. Among the cardiovascular cell types, ESC-derived cardiomyocytes showed clear metabolic changes during the differentiation process. Therefore, we summarize and discuss the metabolic plasticity of cardiomyocytes during development. Metabolic signatures might help to elucidate the role of these genes in pluripotency and differentiation, as well as in modulating the phenotypes of somatic cells derived from stem cells, through the application of gain-and loss-of-function studies and small molecules directed toward the enzymatic activities of the encoded proteins. 
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Metabolic Pathways Involved in the Energetics of PSC Pluripotency
PSCs, including ESCs and iPSCs, are defined by their unique property of self-renewal (stemness) and by their ability to differentiate hierarchically into almost all somatic cell types under certain conditions. Differences in the metabolic processes of PSCs and cancer cells versus other somatic cell types are associated with differences in mitochondrial morphology and mass. It has been shown that PSCs contain fewer and more immature mitochondria with globular shape, poorly developed cristae, and perinuclear localization as compared with the adult differentiated cell types containing a high number of well-developed and elongated or branched mitochondria. 24, 25 Consistently, the voltage difference (ΔΨ) across the mitochondrial inner membrane because of the proton gradient 2, 3 (http://www.biocarta.com/pathfiles/h_etcPathway.asp) is significantly lower in the mitochondria of PSCs compared with differentiated cells. [25] [26] [27] [28] [29] Differentiation of PSCs into somatic cells is accompanied by a shift from cytosolic glycolysis to mitochondrial respiration. In parallel, apoptotic events are most likely initiated by an elevation in heme biosynthesis, reactive oxygen species (ROS) production and by changes in Ca 2+ homeostasis. 30 In addition, some differences have been reported in the metabolism of PSCs between different species.
For instance, human ESCs (hESCs) seem to meet their energy requirements predominantly via anaerobic glycolysis, whereas murine ESCs (mESCs), depending on their specific energy demands, can switch between anaerobic glycolysis in the cytosol and OXPHOS in the mitochondria. 31 The lack of metabolic plasticity and bivalent energy production observed in hESCs may be explained by the lower mitochondrial respiratory capacity observed in hESCs as a consequence of low cytochrome c oxidase expression. 31 Numerous recent studies reported that undifferentiated mESCs and hESCs, as well as human iPSCs (hiPSCs), use anaerobic glycolysis to meet their energy demands, even under conditions of sufficient oxygen supply. 28, 30, 32, 33 This property of stem cells differs from differentiated cell types such as the highly respiring cardiomyocytes. Specifically, mESCs require the activation of the pentose phosphate pathway to prevent ROS-induced cell death. 34 Carbon tracing and gene expression studies confirmed the involvement of the pentose phosphate pathway in addition to the upregulation of lipid biosynthesis in hESCs. 28, 30, 35 More recently, several molecular mechanisms participating in the regulation of energy substrate metabolism during the differentiation of PSCs have been discovered. It has been reported that enzymes regulating glycolysis, such as hexokinase and lactate dehydrogenase, are highly expressed in PSCs, and that their expression is regulated by the mammalian target of rapamycin (mTOR) and phosphoinositide-3-kinase signaling pathways. As in cancer cells, 41, 42 pyruvate influx into the mitochondria is limited by an inactive pyruvate dehydrogenase complex or by the expression of uncoupling protein 2 in PSCs. [27] [28] [29] [30] The expression and incorporation of uncoupling protein 2 into the mitochondrial membrane short-circuit the H + gradient, thereby preventing ATP synthesis. Several cancer cell types also re-express uncoupling protein 2 under certain conditions. 41, 42 All of these mechanisms limit ATP generation by OXPHOS in PSCs or early differentiating cells that preferably rely on glycolysis and its biosynthetic pathways, such as the pentose phosphate pathway. 30 Amino and fatty acid metabolism have also been discussed as being involved in the pluripotency and differentiation of PSCs. In an amino acid screening study performed on mESCs, it was shown that, of 20 amino acids, threonine is required for the survival and growth of mESCs, but not for other highly proliferating cells, such as 3T3 fibroblasts, human cervical carcinoma (HeLa) cells, and mouse embryonic fibroblasts. 43, 44 The importance of Thr for the self-renewal of ESCs and iPSCs has been substantiated after showing that the mitochondrial threonine catabolizing enzyme threonine dehydrogenase (THD) is considerably upregulated in undifferentiated mESCs. 44, 45 Moreover, knockdown and pharmacological inhibition of THD resulted in the disruption of the tightly structured colonies formed by undifferentiated mESCs. 43, 45, 46 THD metabolizes threonine into glycine and Acetyl-CoA. The conversion of Gly by the mitochondrial enzyme glycine decarboxylase (GLDC) also contributes to folate synthesis, which is required for DNA replication. Notably, GLDC has also been found to be highly upregulated in PSCs in comparison with differentiated cells. 43, 45 Acetyl-CoA from the threonine metabolism has been shown to enter the Krebs cycle and finally contributes to ATP synthesis. However, an additional function of the Krebs cycle (less recognized but equally important) is to provide intermediates for biosynthetic pathways, such as the synthesis of fatty acids, nonessential amino acids, and gluconeogenesis. For this reason, it is necessary to maintain a constant flow through the Krebs cycle. If intermediates leave the cycle for biosynthetic purposes, they must be replenished-a process termed anaplerosis. 47 Conversely, reactions that remove Krebs cycle intermediates are termed cataplerotic. An explanation for the higher dependency of ESCs on amino acid metabolism could be that as a result of the Warburg effect, a feature of ESCs, most of the pyruvate converts into lactate in the cytosol and may not enter the Krebs cycle. Therefore, Thr catabolism may be indispensable as a source for Acetyl-CoA. Although experimental proof is only available for threonine, this observation may also apply for other amino acids.
Until now, little was known about lipids and the differentiation of PSCs. Indeed, lipids, in the form of fatty acids, can serve as a source for ATP production by mitochondrial respiration, as has been demonstrated in mESCs by the disruption of carnitine palmitoyltransferase, an enzyme that mediates the transport of fatty acids across the outer mitochondrial membrane, which resulted in the impairment of ATP production.
43,48
Metabolism in Adult Stem and Progenitor Cells
Most adult stem cell types, such as hematopoietic stem cells (HSCs) and muscle satellite cells, exist either as quiescent, slow-cycling stem cells, or in a more proliferative state. The quiescent nature of these cells contributes to their protection from damage and thereby assures tissue regeneration during a long period of time. In general, the main metabolic characteristics of HSCs and satellite cells have been described. 33 The long-term HSC mitochondrial number and mitochondrial membrane potential, as well as their oxygen consumption and intracellular ATP levels, are relatively low. 49 It is assumed that the hypoxic niche within the bone marrow promotes adaptation of HSCs into this phenotype, as hypoxia inhibits the degradation of the hypoxia-inducible factors (HIFs), thereby promoting a transition from oxidative to anaerobic glycolytic metabolism. 50 This transition occurs via the expression of genes, including Glut1, lactate dehydrogenase α (Ldha), and Pdk1, which contributes to the uptake of glucose and the disposal of pyruvate. 31, 50 Notably, HIFs can also promote the expression of stemness factors, such as nanog homeobox (NANOG), sex-determining region Y-box 2 (SOX2), and octamer-binding transcription factor 4 (OCT4), in stem cells including hESCs. 51, 52 Metabolic plasticity because of hypoxic conditions has also been reported for muscle satellite cells. Under hypoxic or anoxic conditions, these cells significantly reduce their mitochondrial number and oxygen consumption and increase their survival compared with other cell types in postmortem tissue. 53 A key signaling pathway that is thought to regulate metabolism and the balance between quiescence and proliferation in HSCs is the phosphoinositide-3-kinase-mTOR pathway. 33, 54, 55 However, until now little is known about the mechanistic aspects aside from the observation that inhibiting mTOR resulted in the elevation of mitochondrial biogenesis and the transition of quiescent HSCs into a more proliferative phenotype, which is associated with impaired hematopoiesis. 54 serine/threonine kinase 11 (LKB1) is a serine/threonine protein kinase that regulates the activity of AMP-activated protein kinase family members and is involved in regulating cell metabolism via the regulation of mitochondrial biogenesis. In this context, it has been shown that the loss of LKB1 in HSCs resulted in impaired ATP synthesis, most likely via a decrease in the number of mitochondria, as well as in their oxidative capacity and membrane potential. 33, 56 These findings correlate with the observation that tricarboxylic acid and glycolytic components were also affected in the LKB1-deficient HSCs, again emphasizing the critical role of LKB1 in the regulation of cellular metabolism (for more details, see the review by Shyh-Chang et al 33, 56 ). In conclusion, hypoxic and anaerobic glycolysis conditions promote a more quiescent HSC phenotype, whereas aerobic glycolysis and OXPHOs (including ROS) conditions promote the proliferative HSC progenitor phenotype (for more details, see the review by Shyh-Chang et al 43 ). A low glycolytic metabolic pathway is also a characteristic of neural and MSCs. In general, OXPHOS (and ROS), in combination with aerobic glycolysis, characterizes the progenitor cells that have differentiated from adult stem cells. For example, osteoblasts and preadipocyte progenitors derived from MSCs show active OXPHOS and ROS metabolic pathways. In contrast, undifferentiated MSCs reduce their oxygen consumption and OXPHOS. Their metabolism is shifted to anaerobic glycolysis (for more details, see the review by Shyh-Chang et al 43 ).
More recently, it has been reported that metabolic processes do indeed play a critical role in the development and differentiation of C2Cl2 myoblasts. 57 An RNA interference approach targeting 50 enzymes involved in carbon metabolism identified 3 carbon-metabolizing enzymes (phosphoglycerate kinase, hexose-6-phosphate dehydrogenase, and ATP citrate lyase) that are involved in the differentiation of C2Cl2 myoblasts into multinucleated myotubes. 57 Impressively, knockdown of these enzymes allowed the differentiation of these cells into multinucleated myotubes even in the presence of serum, although this process normally occurs in low-serum media. Subsequent analysis of the intracellular metabolites in C2Cl2 cells cultured under serum withdrawal as well as under differentiation conditions correlated well with metabolic alterations associated with reduced activity for the 3 aforementioned enzymes. 57 
Metabolism and Epigenetic Plasticity
It is clear that environmental factors, such as nutrition, have a strong impact on cell metabolism. More recently, the association between metabolism and transcriptional control via epigenetic mechanisms has become the subject of intense interest. Potential epigenetic mechanisms that might be modulated by the metabolic activity of cells include chromatin remodeling, histone modifications, DNA methylation, and microRNA pathways. 45, 58, 59 Potential post-translational histone modifications might occur via the targeting of enzymes participating in DNA methylation and histone acetylation by cellular metabolites ( Figure 2 ). The main candidate metabolites for epigenetic DNA modifications are ATP, Acetyl-CoA, S-adenosyl methionine (SAM), and uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc), which provides the substrate during the addition of O-linked N-acetylglucosamine (O-GlcNAc) to proteins ( Figure 2) . Recently, O-GlcNAc has emerged as a critical regulator of diverse cellular processes regulating core components of the pluripotency network. Notably, preventing the formation of O-GlcNAc by inhibiting O-GlcNAc transferase or by reducing the amount of glucose in the media resulted in impaired self-renewal in ESCs and impaired nuclear reprogramming of somatic cells into iPSCs. 60 In general, there is increasing evidence that histone acetylation mediated by histone acetyltransferases is dependent on the intracellular levels of Acetyl-CoA, 58, 61, 62 and NAD + can also act as a epigenetic modifier. 63 Acetyl-CoA is mainly formed by 2 pathways. The first pathway involves the transfer of an acetyl residue from citrate to coenzyme A. This reaction is catalyzed by ATP citrate lyase. The second pathway involves a reaction between acetate and CoA, which is catalyzed by Acetyl-CoA synthase. Evidence concerning the critical role of Acetyl-CoA as an epigenetic modifier comes from reports showing that the inhibition of ATP citrate lyase induces parallel reductions in Acetyl-CoA and histone acetylation levels, which induces the myogenic differentiation of mouse C2C12 myoblasts. 57 In another study, increasing histone acetylation by inhibiting histone deacetylases and DNA methyltransferases increased the efficiency of murine and human somatic cell reprogramming. 64 The acetylation of Lys residues in certain histone H3 tails enables the formation of permissive areas with high transcriptional activity. 65 Intracellular SAM is a supplier for methyl groups, and a recent study demonstrated that a balance between SAM and S-adenosyl homocysteine (SAH) is important for maintaining pluripotency in mESCs. It has been suggested that the balance between SAM and SAH is essential for the trimethylation of H3 at Lys4 (H3-Lys4), most likely via the activation of methyltransferase(s). 45 In this context, it has been reported that THD and the mitochondrial enzyme, GLDC, are involved in the generation of 5-methyl-tetrahydrofolate, thereby inducing trimethylation of H3-Lys4, which is correlating with an open, euchromatin structure required for the epigenetic regulation of the self-renewal state of PSCs. 66, 67 Both THD and GLDC are drastically upregulated in pluripotent ESCs compared with the differentiated state. 43 THD is located in the mitochondria, where it metabolizes threonine into Acetyl-CoA and glycine, which is subsequently metabolized by GLDC to generate 1-carbon equivalents for the folate pool contributing to the generation of the 5-methyl-tetrahydrofolate. Thus, it is clear that there is also a link between amino acid metabolism and post-translational epigenetic regulation. 43, 45 However, it has been reported recently that human threonine dehydrogenase is expressed as a pseudogene encoding truncated proteins that have no activity. 30, 68 Therefore, it remains unclear how human stem cells support folate synthesis and DNA replication independent of functional threonine dehydrogenase.
Lessons From Transcriptome Studies; Amino Acid and Carbohydrate Metabolism Are the Most Prominent Metabolic Signatures in Pluripotent ESCs
Differentiation of PSCs into specific cell lineages is associated with major alterations in metabolism. 57, [69] [70] [71] Apparently, the plasticity of PSCs also implies metabolic plasticity. Previous studies have shown that particularly threonine and glycine metabolism are affected. Metabolism of both amino acids decreases strongly during differentiation. 44, 72, 73 To identify fundamental differentiation networks and pathways during the differentiation of ESCs, we recently published whole-genome gene expression profiling of undifferentiated versus differentiated mESCs. 13, 74, 75 Unique gene clusters clearly depicting their functional participation both at undifferentiated and specific cell-type-associated lineage specification have been identified using clustering techniques. These gene clusters have been used to capture the enrichment of metabolic biological processes and pathways, particularly those associated with energy substrate metabolism. Undifferentiated mESCs were compared with time resolved data of differentiating embryoid bodies (EBs). Moreover, a set of differentiated cardiovascular cell types has been derived from ESCs (Figures 3 and  4) . 13, [77] [78] [79] [80] [81] [82] Figure 3 . Statistical determination of differentially expressed genes from the transcriptome data set of murine embryonic stem cells (ESCs) randomly differentiated into 10-day old embryoid bodies (EBs) (time kinetic, random differentiation). Differentially expressed genes are clustered. Red, black, and green indicate overexpression, medium expression, and low expression, respectively. Among the 10 specific gene clusters obtained genes from clusters 8 and 9, visualized to have a high expression level in undifferentiated ESCs, and clusters 2 and 3, including genes with a low expression level, were chosen to identify unique metabolism-related genes using the David Functional Enrichment tool (meta-analysis of gene microarray data as described previously 13 ). K-means cluster analysis was performed after transcriptwise normalization of signal values to a mean of 0 and SD of 1 using Euclidean distance measurement and k=10, using cluster 3.0 tool from the Eisen laboratory. 76 gave us the possibility to identify genes with a higher expression in ESCs compared with all stages of EBs ( Figure 5A ) and compared with the above-mentioned differentiated cardiovascular cell populations ( Figure 5B ). This comparison identified genes of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways glycine, serine, and threonine; cysteine and methionine; arginine and proline; valine, leucine, and isoleucine; tryptophan and lysine metabolism (Table) . The findings provide strong evidence that high levels of amino acid biosynthesis and metabolism are characteristic of the pluripotent state. The cysteine and methionine metabolism genes identified are crucial for the formation of SAM, which has been demonstrated to be critical for maintaining pluripotency in mESCs via the trimethylation of H3 at Lys4 (H3-Lys4). 45 In agreement with this observation, DNMT3L, which recognizes and methylates the unmethylated H3-Lys4, 83 has been found to be highly expressed as well. The identification of the glycine, serine, and threonine metabolism confirms previous studies reporting that threonine is essential for the stemness and self-renewal of ESCs. [84] [85] [86] In this context, it has been shown that 1-carbon metabolism is typical for undifferentiated ESCs. In accordance with our findings, threonine dehydrogenase is also highly expressed in ESCs. The threonine dehydrogenasemediated metabolism of threonine occurs in mitochondria to generate glycine and facilitate 1-carbon metabolism via the glycine cleavage system and Acetyl-CoA, which enters the Krebs cycle for ATP production. 44, 86 Accordingly, genes, such as Mthfd2, Folr1, and Pipox, which belong to the folic acid and derivative metabolic process, show high expression levels in ESCs. More recently, it has been shown that serine biosynthesis can also occur with 1-carbon catabolism. The glycine cleavage system resulting in the production of ATP, and the upregulation of serine and glycine biosynthesis was observed in various tumors. 87 Interestingly, the arginine and proline pathways have been identified as prominent metabolic pathways enriched during the reprogramming of fibroblasts into iPSCs. 88 The valine, leucine, and isoleucine degradation genes are essential for the degradation of these essential amino acids to yield NADH and flavin adenine dinucleotide 2 for ATP generation. The lysine degradation genes were found to be upregulated in ESCs and might contribute to the generation of Acetyl-CoA for further generation of ATP by OXPHOS. It is striking that catabolism of the amino acids Val, Leu, Ile, Lys, and Thr, which is upregulated in undifferentiated stem cells, leads to the formation of Acetyl-CoA and numerous intermediates of the Krebs cycle, including oxaloacetate, α-ketoglutarate, fumarate, and succinyl-CoA. These intermediates are known to fulfill important anaplerotic and cataplerotic functions in the Krebs cycle. 49 Therefore, it is possible that increased metabolism of amino acids in undifferentiated ESCs is required to maintain the Krebs cycle functioning, as proposed for Thr in a previous section.
Another prominent and unique metabolic signature of undifferentiated ESCs is the higher expression (≥2-fold) of genes involved in carbohydrate metabolism. These genes belong to the glycolysis/gluconeogenesis, galactose, fructose and mannose, and starch and sucrose KEGG pathways (Table) . In general, the genes found in these KEGG pathways have also been identified in the GO_BP related to carbohydrate metabolism and the gene ontology monosaccharide metabolic process. Gaa, Hk1, and Sord show high expression levels in undifferentiated ESCs, low expression levels early on in the differentiation processes (through day 4 EBs), and again high expression levels at later points of differentiation (days 5-10). Hexokinase 1 (HK1) is located on the outer mitochondrial membrane and is highly . K-means cluster analysis was performed after transcript-wise normalization of signal values to a mean of 0 and SD of 1 using Euclidean distance measurement and k=10, using cluster 3.0 tool from the Eisen laboratory. 76 αMHC indicates α-myosin heavy chain; and BMP2, bone morphogenetic protein 2. Adapted from Doss et al 77 with permission of the publisher. Authorization for this adaptation has been obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation (copyright year 2011, Springer). upregulated in malignant tumor cells, thereby promoting aerobic glycolysis. 89 Gaa encodes acid α-glucosidase, which initiates the degradation of glycogen to glucose in lysosomes, whereas Sord converts sorbitol to fructose. In summary, the data suggest that amino acids and carbohydrates serve as energy sources for undifferentiated ESCs. They are used to generate pyruvate, which fuels OXPHOS for the generation of ATP.
Lessons From Transcriptome Studies; Lipid Metabolic and Hydrogen Peroxide-Associated Genes Show Low Expression Levels in ESCs
Typical features of ESCs are high concentrations of unsaturated fatty acids that offer carbon-carbon double bonds for oxidation and further metabolism into eicosanoids. It has been proposed that eicosanoids are required for ESC pluripotency and that their oxidation by ROS initiates ESC differentiation. 70 This hypothesis is supported by the observation that pharmacological inhibition of the enzymes participating in eicosanoid synthesis and the oxidation of unsaturated fatty acids inhibits the differentiation of ESCs. 70 Interestingly, genes, such as Sc5d, Sh3glb1, Fads2, Pbx1, and Fabp5, which belong to the lipid biosynthetic process, show low expression levels in undifferentiated mESCs compared with all the other more differentiated cell populations ( Figure 5C and 5D ). Sterol-C5-desaturase (Sc5d; or lathosterol 5-desaturase) encodes an enzyme required for cholesterol biosynthesis. 90 Sh3glb1 encodes a sarcoma (SRC) homology 3 domain-containing protein that may act as a proapoptotic factor and may also be involved in maintaining mitochondrial morphology. 91 Fatty acid desaturase (FADS)2 catalyzes the biosynthesis of highly unsaturated fatty acids from the polyunsaturated fatty acids linoleic acid (18:2n-6) and α-linolenic acid. 92 Pre-B-cell leukemia homeobox (PBX)1 is involved in steroidogenesis, sexual development, and differentiation, 93 and fatty acid binding protein (FABP)5 influences fatty acid uptake, transport, and metabolism. 94 Expression of the very low-density lipoprotein receptor (Vldlr; steroid metabolic process) and Ghr (fatty acid metabolic process) genes was suppressed in undifferentiated ESCs. In summary, these results suggest that lipid biosynthesis and metabolism are significantly suppressed in undifferentiated ESCs. Notably, Gpx1, Pxdn, Prdx2, and Cd24a, which belong to the oxygen and reactive oxygen species metabolic process gene ontology, were expressed at low levels. Glutathione peroxidase 1, which is required for the detoxification of hydrogen peroxide, is one of the most important antioxidant enzymes in humans and has been found to have a low expression level in undifferentiated ESCs and iPSCs cells. 95 Peroxidasin Homolog (PXDN) and Peroxiredoxin 2 (PRDX2) may play an important role in eliminating peroxides generated during metabolism. 96, 97 Apparently, low levels of ROS (such as peroxides) may be required for the pluripotency of ESCs. This finding confirms the proposed hypothesis that intact eicosanoids are required for ESC pluripotency, and that the oxidation of eicosanoids by ROS initiates ESC differentiation.
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Lessons From Transcriptome Studies; Metabolic Gene Expression Signatures of Cardiomyocytes Derived From mESCs
Up until now, there are limited transcriptome studies for identifying unique metabolic gene expression signature of mesodermal cells and their cardiovascular derivatives (Figure 4 , adapted from Doss et al 77 ) . In a comprehensive genome-wide study, clusters of highly correlated genes were identified that differ between mature cardiomyocytes and their stem cell progenitors. One gene cluster comprised 499 genes upregulated in α−MHC + cardiomyocytes compared with mesodermal cell populations and their derivatives. 77 Among these genes, Acaa2, Ndufab1, Prkaa2, Dci, and Qk were identified, which are required for fatty acid metabolism. Acetyl-CoA acyltransferase 2 (Acaa2) encodes for a mitochondrial matrix enzyme that catalyzes fatty acid β-oxidation occurring in the mitochondria. 98 NADH dehydrogenase (Ubiquinone) 1, α/β subcomplex, 1, 8 kDa (NDUFAB1) is also a mitochondrial protein subcomplex that is involved in the transfer of electrons from NADH to the respiratory chain. 99 Protein kinase, AMP-activated, α-2 catalytic subunit (PRKAA2) activates many catabolic pathways, including fatty acid metabolism, to ensure a high levels of ATP production. 100 Enoyl-CoA Δ-isomerase 1 (Dci) encodes for a key mitochondrial protein involved in the β-oxidation of unsaturated fatty acids. 101 Notably, among the genes upregulated in α-MHC + cardiomyocytes, we identified Ppp1r3c, Pygm, Eno3, Pgam2, Pfkm, Agl, and Mdh1, which are involved in glucose metabolism. Protein phosphatase 1, regulatory subunit 3C (PPP1R3C), phosphorylase, glycogen, muscle (PYGM), enolase 3 (β, muscle; ENO3), phosphoglycerate mutase 2 (muscle; PGAM2), and amylo-α-1,6-glucosidase, 4-α-glucanotransferase (AGL) regulate the degradation of glycogen into glucose (glycogenolysis). 99, [101] [102] [103] [104] [105] [106] [107] [108] Phosphofructokinase, muscle (PFKM) catalyzes the phosphorylation of fructose-6-phosphate during glycolysis. 104 Malate dehydrogenase 1 (MDH1) is involved in gluconeogenesis. 106 Indeed, these genes can be targeted to manipulate the differentiation of ESCs into specific cardiomyocyte phenotypes or to modulate the maturation grade of cardiomyocytes derived from ESCs. In this context, it has been demonstrated that immature cardiomyocytes from fetal heart metabolize lactate to produce pyruvate to drive OXPHOS for ATP generation. This observation has been applied to selectively differentiate ESCs into proliferating and functional cardiomyocytes, whereas other differentiated and undifferentiated ESCs or iPSCs were eliminated because of lactate metabolic intolerance. 109 In contrast to the strident metabolic signature of the α−MHC + cardiomyocytes, analysis of the other cluster of genes that were exclusively upregulated in 1 cell population (eg, genes in cluster 6, which were upregulated in CD31 + cells) or 2 cell populations, for example, genes in cluster 8, which were upregulated in α-smooth muscle actin 2 (Acta2) smooth muscle cells and in CD31 + cells, or genes in cluster 1, which were upregulated in the mesodermal populations Tbra + and bone morphogenetic protein 2 + cells, do not enrich any cell-type-specific metabolic signature. Transcriptome analysis has revealed that genes belonging to the heart-specific KEGG pathways OXPHOS and the different GO categories, for example, mitochondrion, cytochrome c oxidase activity, and fatty acid metabolisms, which are associated with aerobic energy production, were also downregulated in cardiomyocytes derived from murine iPSCs compared with the heart tissues isolated from E18 fetal, neonatal, and 2-month-old heart tissues. This suggests that the transcriptome of the Acta2 + cardiomyocytes is more similar to fetal than to 2-month-old heart tissues. 110 Similar to murine iPSCsderived cardiomyocytes, 111 it has been reported more recently that the transcriptome of the hESC-derived cardiomyocytes is also similar to fetal cardiomyocytes in comparison with adult cardiomyocytes.
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Metabolism of Adult Cardiomyocytes
It is widely accepted that >90% of the energy requirements of adult cardiomyocytes are covered by OXPHOS in the mitochondria. 113, 114 Under normal physiological conditions, fatty acid oxidation is essential for adult cardiomyocytes and predominates over the oxidation of other nutrients.
In general, similar to adult cardiomyocytes, cardiomyocytes derived from mESCs possess a gene expression signature associated with fatty metabolism and glycolysis (see text above). 82 Pending on the conditions, adult cardiac cells are metabolically flexible, being capable of oxidizing other energy sources, such as glucose, lactate, amino acids, and ketone bodies, for generating ATP and non-ATP-producing intermediate metabolites with high biological significance. [113] [114] [115] For instance, lactate that is produced by skeletal muscles during extensive exercise conditions can be oxidized by cardiomyocytes and finally contribute to the ATP synthesis. [115] [116] [117] Similarly, ketone bodies can also be metabolized by adult cardiomyocytes as demonstrated by a diet-fed mouse model (mice were fasted for 24 hours and then subjected to a low carbohydrate ketogenic diet). 118 In addition, glucose and fatty acid oxidation was significantly suppressed after addition of lactate or ketone bodies in isolated perfused rat hearts. 115, [119] [120] [121] Therefore, it has been assumed that the ability of cardiomyocytes to adapt their metabolism to substrate availability may be critical for their contraction balance under different physiological and pathophysiological condition. 115 A few studies suggest that triacylglycerols regulate the fatty acid metabolism in the adult cardiomyocytes, as demonstrated by the diacylglycerol acyl transferase 1 (Dgat1) knockout mouse model. 115, 122 Loss of DGAT1, which catalyzes the synthesis of triacylglycerols from diacylglycerol in heart muscles, was associated with significant changes in lipid uptake and oxidation. The heart of the Dgat1 knockout mice decreased fatty acid oxidation and an increased glucose uptake. 115, 122 In contrast, overexpression of the Dgat1 in the mouse heart resulted in an increase of fatty acid uptake and oxidation. 115, 123 The metabolic flexibility of adult cardiomyocytes can be regulated by allosteric interactions of substrates and their metabolites, thus modulating the activity of key metabolic enzymes. 115 An additional level of regulation is translation of key proteins required for a specific metabolic switch. 115 In this context, it has been shown that a switch of glycolysis, predominantly occurring in fetal heart, to fatty acid oxidation, normally occurring in the adult heart, requires upregulation of fatty acid-metabolizing proteins mediated by the nuclear hormone receptors, such as peroxisome proliferator-activated receptor γ and the estrogen-related receptor or the peroxisome proliferator-activated receptor γ coactivator-1 α protein.
Another example of metabolic plasticity in cardiomyocytes is demonstrated by the expression of Hif-1a, which is essential for metabolic adaptation of the cardiomyocytes to hypoxic and ischemic conditions. 124 Finally, a switch between glucose and fatty acid oxidation in cardiomyocytes can also be regulated by post-translational modifications. For instance, the key metabolic enzymes, such as pyruvate dehydrogenase, can be inactivated by the pyruvate dehydrogenase kinase 4.
115,125
Metabolic Alterations During the Development of Cardiomyocytes
Glycogen metabolism has been described to play a key role for heart development, as demonstrated by disruption of the glycogen synthase isoform 1 (Gys1) in mice. Defects in cardiac development have been observed after 11.5 and 14.5 days post coitum. GYS1-null mice showed impaired cardiac function and died after birth. 126 During cardiac development and differentiation, energy substrate metabolism is dramatically changed in several species (extensively reviewed 113, 114 ). The following main energy substrate metabolism features for the fetal, newborn, and neonatal heart have been described: (1) because of the low oxygen conditions of the fetal heart, mainly (anaerobic) glycolysis contributes to ATP production. Only <15% of the ATP is produced by the fatty acid β-oxidation pathway. It has been suggested that proliferation of fetal cardiomyocytes during cardiac development is characterized by high rates of glycolysis and lactate production. In addition, the oxidative capacity of cardiomyocytes in the fetal heart is high. 113, 114 (2) Similar to the fetal also the neonatal heart fuels glucose and lactate for ATP generation immediately after birth with only minor contribution of fatty acids to total ATP production. However, a few days after birth, glycolysis rapidly decreases in the neonatal heart and provides <10% of total ATP production as also observed in the adult heart. 111, 113, 114, 127 More recently, it has been demonstrated that mitochondrial morphology is critical for cardiomyocyte development. In this regard, in vivo developmental experiments demonstrated that ablation of cardiac-specific mitochondrial fusion proteins, mitofusin 1 and 2 (MFN1 and MFN2), resulted in an inhibition of mouse heart development. 128 Interestingly, inactivation of Mfn2 or optic atrophy by gene trapping also impaired differentiation of mESCs to cardiomyocytes. 128 Transcriptome analysis of the control and Mfn1-and Mfn2-ablated E9.5 embryos indicated an inhibition of transforming growth factor-β and the transcription factors serum response factor (Srf), Gata4, Nkx.2.5, and myocardin (Myocd), which are essential for cardiomyocyte development. 128 This suggests that mitochondrial fusion promotes cardiomyocyte differentiation via calcineurin, intracellular Ca 2+ concentration, and the Notch signaling pathways. 128 From the observation that electron transport chain complex III inhibition in mESCs did block differentiation toward cardiomyocytes, it has been proposed that mitochondrial complex III is necessary for cardiomyocyte differentiation. 129 Because inhibition of the electron transport chain complex III in mESC-derived early cardiomyocytes was accompanied by an impaired activity of Ca 2+ oscillations, it has been postulated that Ca 2+ oscillations are essential for cardiomyocyte differentiation.
129
Protective Metabolic Pathways for Cardiomyocytes
More recently, several cardioprotective metabolic pathways have been recognized. The main catabolic pathway of glucose uses oxidation of pyruvate and OXPHO-depending ATP synthesis. Alternatively, the glucose-6-phosphate (G6P) intermediate of the glycolytic pathway is capable of entering the pentose phosphate pathway in cardiomyocytes, thereby generating nicotinamide adenine dinucleotide phosphate (NADPH) and contributing to cardiomyocyte contractility. 115, 130, 131 It has been proposed that NADPH is crucial for the maintenance of the reduced glutathione and therefore acts protectively against the ROS-induced cell injury. 132 In good agreement with the above observation, G6P dehydrogenase (G6PD) lacking mice showed much more severe heart damage induced by the myocardial ischemia-reperfusion injury in Langendorff-perfused hearts as compared with wild-type mice. 133 These results further emphasize the cardioprotective role of the pentose/G6PD/ NADPH/glutathione pathway. UDP-GlcNAc, an intermediate metabolite of the glycolytic pathways, serves as a substrate for the O-GlcNAc transferase and O-GlcNAcase, both catalyzing the reversible addition of the O-GlcNAc residue to >1000 target proteins in the human cell. 134 Protein O-GlcNAcylation by both enzymes seems to play a significant role in several biological processes. 134 Notably, recent studies demonstrated that O-linked GlcN protein acylation by GlcNAcase acts as a cardioprotective mechanism against heart injury.
118, [135] [136] [137] In addition, O-GlcNAc plays also an important role for self-renewal in ESCs and nuclear reprogramming of somatic cells into iPSCs. 60 Transketolase is also a key enzyme of the pentose phosphate pathway. The activity of both enzymes was found to be significantly reduced in diabetes mellitus mice hearts, leading to excessive glycation of proteins and lipids, thereby inhibiting Akt signaling and prosurvival Pim-1/Bcl-2.
138,139 Cardiac progenitor cells (CPC) have been postulated as cardiac stem cells playing an important role in heart regeneration. Although the metabolism and bioenergetics pathways of the CPC are to date widely unknown, the crucial role of the pentose phosphate pathway in CPC survival has been demonstrated in CPC isolated from the heart of mice. 140 In this context, it has been reported 140 that diabetes mellitus markedly reduces the activity of G6PD and transketolase resulting in apoptosis of cardiomyocytes by similar mechanisms as described above. 138, 139 Interestingly, culture of murine CPCs in high glucose-induced activation of apoptosis via inhibition of the pentose phosphate pathway mediated prosurvival signaling pathways. 140 In conclusion, the pentose/G6PD/NADPH/glutathione pathway plays a key role in protection of cardiomyocytes.
Conclusions and Future Directions
Knowledge about the impact of the energy substrate metabolic switch during mammalian development and differentiation of pluripotent and adult stem cells is drastically growing. During differentiation of PSCs and adult stem cells, such as MSC, a metabolic and mitochondrial respiration switch is required to cover the ATP energy demands of the differentiated somatic cells. Accordingly, differentiation of highly proliferative PSCs into less proliferative somatic cells, such as cardiomyocytes, is accompanied by a shift from cytosolic anaerobic glycolysis to mitochondrial respiration and in parallel with more apoptotic events. It has also been recognized that cellular key metabolites derived from the oxidation of glucose, lactate, fatty acids, and amino acids are critical regulators of the pluripotency networks and other biological processes.
Key metabolites and enzymes participating in histone acetylation and DNA methylation induce epigenetic modifications of the genome and are consequently crucial regulators of the pluripotent and differentiated states of stem cells. Evidently, the metabolic switch of stem cells represents an important determinant of cell fate. Comparative whole-genome transcriptomes of differentiated mESCs and mesodermal cell lines (Tbra + cells, BMP2 + cells) and their derivatives (cardiomyocytes, smooth muscle cells, and endothelial-like cells) obtained from mESCs have revealed unique metabolic gene signatures for the undifferentiated ESCs and for ESC-derived cardiomyocytes. Altogether, amino acid, carbohydrate, lipid and hydrogen peroxide-associated metabolism seem to be crucial for the maintenance of pluripotency with amino acid metabolism being a particularly important key process. In view of the importance of amino acid catabolism in the generation of Krebs cycle intermediates, we are inclined to propose that the physiological relevance of increased metabolism of amino acids in ESCs may be to maintain proper and continuous functioning of the Krebs cycle that would otherwise not be functional because of higher conversion of pyruvate to lactate.
In contrast to undifferentiated ESCs, fatty acid and glucose metabolism, along with mitochondria respiration, seems to be crucial for ESC-derived cardiomyocytes. Thus, metabolic hallmarks of undifferentiated stem cells and their differentiated counterparts are beginning to be understood. Another interesting aspect is the flexibility of energy substrate metabolism during cardiac development and differentiation. During progressive cardiac development and differentiation, the contribution of the (anaerobic) glycolysis to ATP synthesis rapidly decreases, whereas simultaneously fatty acid-dependent mitochondrial respiration increases drastically. The metabolism of the iPSC-derived cardiomyocytes shows more similarities to the fetal cardiomyocytes than to the adult phenotype, indicating that the metabolic switch during in vitro differentiation may have not have fully evolved to the metabolic status of adult cardiomyocytes. Finally, the pentose phosphate metabolic pathway plays an important role for the survival of both, undifferentiated ESCs and cardiomyocytes, probably via prevention of ROS formation. In summary, the identification of cell-specific metabolic pathways provides novel insights into the regulation of the differentiation of stem cells and enables the development of new strategies for stem cell differentiation based on defined media components or on targeting key metabolic pathways. Accordingly, investigations have been started to identify critical metabolic components to specifically dedifferentiate PSCs into organ-specific somatic cell types. Exemplarily, this strategy has been successfully applied recently by enriching cardiomyocytes from PSCs using lactate-enriched culture media, which is well tolerated by cardiomyocytes, but not by other differentiated cells. 109 An attractive future perspective of this field of research is to exploit the recently generated knowledge on metabolic key processes to generate mature stem cell-derived somatic cells for therapeutic applications without the requirement of genetic manipulation. 
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